Monday, December 8, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates EqualWeight Rating for Oracle with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Neurotechnology
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On March 12, 2024, analyst Keith Weiss from Morgan Stanley reiterated an Equal-Weight rating for Oracle (NYSE: ORCL) while increasing the price target to $115 from $106. This adjustment signifies Weiss’s positive outlook on the company’s performance moving forward. Across the board, analysts have a generally optimistic view of Oracle, with price targets ranging from $83 to $160. Morgan Stanley’s decision falls in line with the overall market sentiment regarding Oracle’s stock performance and growth prospects.

Oracle Corporation (ORCL) Stock Surges on March 12, 2024: Positive Signs for Investors

On March 12, 2024, Oracle Corporation (ORCL) experienced a strong performance in the stock market. The price of ORCL shares saw a significant increase on this particular day, with a rise of $1.71 since the market last closed, representing a 1.52% increase in the stock price, closing at $114.13. Additionally, in pre-market trading, the stock rose an impressive $13.02. Investors and analysts may view these price movements as a bullish sign for ORCL, potentially indicating positive sentiment towards the company and its future prospects. The rise in the stock price on March 12th could be attributed to positive news or developments related to Oracle Corporation. Overall, the performance of ORCL on March 12, 2024, was impressive, with the stock showing strong price momentum and significant gains. Investors will likely be monitoring the stock closely to see if this positive trend continues in the days and weeks ahead.

Oracle Corporation (ORCL) Reports Strong Financial Performance with 17.7% Revenue Growth

On March 12, 2024, Oracle Corporation (ORCL) saw a strong performance in terms of its financials. The tech giant reported total revenue of $49.95 billion for the past year, which marked a 17.7% increase compared to the previous year. Net income for Oracle stood at $8.50 billion for the year, showing a significant 26.59% increase from the previous year. Earnings per share (EPS) for Oracle also showed positive growth, with a reported EPS of $3.07 for the year, marking a 27.5% increase from the previous year. Investors may view these positive financial metrics as a sign of the company’s continued success and potential for future growth.

Tags: ORCL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Navigating Challenges and Prioritizing Growth Kohls Q4 Financial Performance Recap

DVY stock news

Analysts Bullish on Nateras Future Growth

3M Announces New CEO Amid Restructuring and Market Challenges

Recommended

Blink Charging Stock

Blink Charging’s Critical Earnings Test Approaches

1 month ago
Centrus Energy Stock

A Quiet Leader Emerges in the Nuclear Energy Revival

3 months ago
Costco Stock

Costco’s Bold Membership Strategy: Rewarding Premium Customers

3 months ago
UiPath Registered (A) Stock

UiPath Leadership Under Scrutiny Ahead of Earnings Report

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Prospect Capital Faces Analyst Doubts Amid Strategic Shift

Lennar Shares Face Cautious Outlook Amid Housing Market Uncertainty

Bath & Body Works Stock: Assessing the Post-Candle Day Landscape

IBM’s Strategic Gambit: A Potential $11 Billion Acquisition of Confluent

Analyst Confidence Rises for Royal Gold’s Stock Trajectory

Arrowhead Pharmaceuticals Enters Commercial Era with Landmark Drug Approval

Trending

Pony AI Stock
AI & Quantum Computing

Pony AI Gains Momentum with Strategic Moves and Institutional Backing

by Felix Baarz
December 8, 2025
0

The autonomous driving technology firm Pony AI is entering the week bolstered by a series of strategic...

Ginkgo Bioworks Holdings Registered (A) Stock

Ginkgo Bioworks Shares Surge on Major Government Contract Win

December 8, 2025
AbbVie Stock

Navigating Oncology Rivals: AbbVie’s Strategic Position Under Scrutiny

December 8, 2025
Prospect Capital Stock

Prospect Capital Faces Analyst Doubts Amid Strategic Shift

December 8, 2025
Lennar Stock

Lennar Shares Face Cautious Outlook Amid Housing Market Uncertainty

December 8, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pony AI Gains Momentum with Strategic Moves and Institutional Backing
  • Ginkgo Bioworks Shares Surge on Major Government Contract Win
  • Navigating Oncology Rivals: AbbVie’s Strategic Position Under Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com